Skip to main content
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.150
-0.110 (-2.58%)
At close: Jun 27, 2025, 4:00 PM
4.190
+0.040 (0.96%)
After-hours: Jun 27, 2025, 6:15 PM EDT

Aurora Cannabis Revenue

In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M CAD with 27.32% growth. Aurora Cannabis had revenue of 90.54M in the quarter ending March 31, 2025, with 34.31% growth.

Revenue (ttm)
343.29M CAD
Revenue Growth
+27.32%
P/S Ratio
1.00
Revenue / Employee
319,938 CAD
Employees
1,073
Market Cap
238.70M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025343.29M73.66M27.32%
Mar 31, 2024269.64M45.83M20.48%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021245.25M-23.45M-8.73%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

ACB News

More News